{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:34:34Z","timestamp":1784291674933,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","award":["82204244"],"award-info":[{"award-number":["82204244"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["23NSFSC2370"],"award-info":[{"award-number":["23NSFSC2370"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.fitote.2024.106141","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T16:17:38Z","timestamp":1721751458000},"page":"106141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Design, synthesis and anti-Alzheimer's disease activity evaluation of C-3 arylated huperzine A derivatives"],"prefix":"10.1016","volume":"177","author":[{"given":"Xiao-Xing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Xi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fitote.2024.106141_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.fitote.2024.106141_bb0010","first-page":"313","article-title":"The epidemiology of Alzheimer's disease modifiable risk factors and prevention","volume":"3","author":"Zhang","year":"2021","journal-title":"J. Prev. Alz. Dis."},{"key":"10.1016\/j.fitote.2024.106141_bb0015","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acschemneuro.3c00656","article-title":"Novel dual-acting hybrids targeting type-2 cannabinoid receptors and cholinesterase activity show neuroprotective effects in vitro and amelioration of cognitive impairment in vivo","volume":"15","author":"Mugnaini","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.fitote.2024.106141_bb0020","first-page":"4181","article-title":"Can small molecules provide clues on disease progression in cerebrospinal fluid from mild cognitive impairment and Alzheimer's disease patients?","volume":"58","author":"Talavera And\u00fajar","year":"2024","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.fitote.2024.106141_bb0025","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent advancements in pathogenesis, diagnostics and treatment of alzheimer\u2019s disease","volume":"18","author":"Khan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.fitote.2024.106141_bb0030","article-title":"Disease-modifying treatments and their future in Alzheimer's disease management","volume":"16","author":"Smith","year":"2024","journal-title":"Cureus J. Med. Sci."},{"key":"10.1016\/j.fitote.2024.106141_bb0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.fitote.2024.106141_bb0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1517\/14740338.3.5.425","article-title":"The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease","volume":"3","author":"Thompson","year":"2004","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.fitote.2024.106141_bb0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11101-014-9384-y","article-title":"Huperzine a from huperzia serrata: a review of its sources, chemistry, pharmacology and toxicology","volume":"15","author":"Ferreira","year":"2016","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.fitote.2024.106141_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jep.2007.05.030","article-title":"Huperzine a from huperzia species \u2013 an ethnopharmacolgical review","volume":"113","author":"Ma","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.fitote.2024.106141_bb0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/0929867003375281","article-title":"Huperzine a, a potential therapeutic agent for treatment of Alzheimer\u2019s disease","volume":"7","author":"Bai","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106141_bb0060","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/10286020.2023.2196619","article-title":"Palladium-catalyzed synthesis and acetylcholinesterase inhibitory activity evaluation of 1-arylhuperzine a derivatives","volume":"25","author":"Xu","year":"2023","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.fitote.2024.106141_bb0065","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1021\/ja9622822","article-title":"Identification of a more potent analogue of the naturally occurring alkaloid huperzine a. predictive molecular modeling of its interaction with ache","volume":"118","author":"Kozikowski","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.fitote.2024.106141_bb0070","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1021\/acs.jnatprod.1c00600","article-title":"Pd-catalyzed direct diversification of natural anti-Alzheimer\u2019s disease drug: synthesis and biological evaluation of N-aryl huperzine a analogues","volume":"84","author":"Miao","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.fitote.2024.106141_bb0075","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bmcl.2012.11.083","article-title":"Structural analogs of huperzine a improve survival in guinea pigs exposed to soman","volume":"23","author":"Gunosewoyo","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.fitote.2024.106141_bb0080","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/jm0496178","article-title":"Bis-huperzine B: highly potent and selective acetylcholinesterase inhibitors","volume":"48","author":"Feng","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106141_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nsb0197-57","article-title":"Structure of acetylcholinesterase complexed with the nootropic alkaloid, (\u2212)-huperzine a","volume":"4","author":"Raves","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.fitote.2024.106141_bb0090","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1002\/anie.201301737","article-title":"Transmetalation in the Suzuki\u2013miyaura coupling: the fork in the trail","volume":"52","author":"Lennox","year":"2013","journal-title":"Angew. Chem. Int. Edit."},{"key":"10.1016\/j.fitote.2024.106141_bb0095","doi-asserted-by":"crossref","first-page":"19924","DOI":"10.1021\/acsomega.1c02875","article-title":"In silico-guided rational drug design and semi-synthesis of C(2)-functionalized huperzine a derivatives as acetylcholinesterase inhibitors","volume":"6","author":"Anukanon","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.fitote.2024.106141_bb0100","doi-asserted-by":"crossref","first-page":"23646","DOI":"10.1074\/jbc.271.39.23646","article-title":"Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase: steps toward novel drugs for treating Alzheimer\u2019s disease","volume":"271","author":"Pang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fitote.2024.106141_bb0105","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/01.WNL.0000140626.48118.0A","article-title":"A focus on the synapse for neuroprotection in Alzheimer disease and other dementias","volume":"63","author":"Coleman","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.fitote.2024.106141_bb0110","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106141_bb0115","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1021\/jm000980y","article-title":"New tacrine\u2212huperzine a hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of alzheimer\u2019s disease","volume":"43","author":"Camps","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106141_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116353","article-title":"Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2h)-one as potent bche-selective inhibitors showing protective effects against neurodegenerative insults","volume":"270","author":"Samarelli","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106141_bb0125","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1016\/j.bmc.2018.08.035","article-title":"Design, synthesis, and biological evaluation of selective and potent carbazole-based butyrylcholinesterase inhibitors","volume":"26","author":"Ghobadian","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106141_bb0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cbi.2016.04.022","article-title":"Reduced fibrillar \u03b2-amyloid in subcortical structures in a butyrylcholinesterase-knockout alzheimer disease mouse model","volume":"259","author":"Darvesh","year":"2016","journal-title":"Chem. Biol. Interact."}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X24003241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X24003241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T06:02:44Z","timestamp":1723096964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X24003241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":26,"alternative-id":["S0367326X24003241"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2024.106141","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anti-Alzheimer's disease activity evaluation of C-3 arylated huperzine A derivatives","name":"articletitle","label":"Article Title"},{"value":"Fitoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fitote.2024.106141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106141"}}